Asse, Belgium

Kris Van Den Abeele

This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Capsugel Belgium Nv. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kris Van Den Abeele. Retrieved from https://idiyas.com/inventor/kris-van-den-abeele

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kris Van Den Abeele - Innovator in Capsule Technology

Introduction

Kris Van Den Abeele is an inventive mind based in Asse, Belgium. He is currently associated with Capsugel Belgium NV, where he focuses on developing innovative solutions in capsule technology. Despite having no granted patents to his name, his contributions to the field are noteworthy.

Latest Patent Applications

Kris Van Den Abeele's latest patent application is titled "Capsule with Reduced Powder Leakage." This invention pertains to a capsule shell composed of two parts: a cap and a body. The two parts engage telescopically with each other, allowing the capsule shell to store solid substances in powder or granular form. This design minimizes the leakage rate of powder when the capsule shell is filled and closed, showcasing a significant advancement in capsule technology.

Conclusion

Kris Van Den Abeele's work in capsule technology, particularly his latest patent application, highlights his innovative approach to solving practical challenges in the industry. His contributions, although not yet reflected in granted patents, demonstrate his commitment to advancing the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…